New narcolepsy pill tested for side effects

NCT ID NCT07051252

Completed Symptom relief Sponsor: Harmony Biosciences Management, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested how well adults with narcolepsy tolerated a new, delayed-release version of a medication called pitolisant. The goal was to see if starting at the full treatment dose caused too many side effects or led people to stop taking it. Researchers monitored 46 participants over a short period to check for safety issues.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Harmony Site 1

Cincinnati, Ohio, 45245, United States
Harmony Site 10

Denver, North Carolina, 28037, United States
Harmony Site 11

Troy, Michigan, 48085, United States
Harmony Site 12

North Charleston, South Carolina, 29406, United States
Harmony Site 13

Newton, Massachusetts, 02459, United States
Harmony Site 14

Brandon, Florida, 33511, United States
Harmony Site 15

Wyomissing, Pennsylvania, 19610, United States
Harmony Site 2

Huntersville, North Carolina, 28078, United States
Harmony Site 3

Austin, Texas, 78731, United States
Harmony Site 4

Miami, Florida, 33176, United States
Harmony Site 5

Columbia, South Carolina, 29201, United States
Harmony Site 6

Canton, Ohio, 44718, United States
Harmony Site 7

Morgantown, West Virginia, 26506, United States
Harmony Site 8

Atlanta, Georgia, 30328, United States
Harmony Site 9

San Ramon, California, 94583, United States

Conditions

Explore the condition pages connected to this study.

NARCOLEPSY